Our current study includes assessment of select ABC superfamily gene members (including ABCB1, ABCC1, ABCC2 and ABCG1) known to act as active drug transporters to reduce accumulation of chemotherapy drugs within resistant cancer cells [33,34,35,36]. This evidence concerns the gene ABCC1 and cancer.